SCHEMBL450968

SCHEMBL450968

OCCN(Cc1cccc(Oc2ccccc2)c1)Cc1ccc2cc(OCCCCCc3ccccc3)ccc2c1

nearest known ligand 0.56

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.56
HSD17B10 Q99714 1/20 0.56
BCHE P06276 11/20 0.46
PPARG P37231 5/20 0.46
PPARA Q07869 5/20 0.46
ACHE P22303 3/20 0.44
FAAH O00519 1/20 0.42
LPAR1 Q92633 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL451860 0.96 TSHR (0.49) TSHRHSD17B10BCHEPPARGPPARA
SCHEMBL451492 0.92 BCHE (0.56) TSHRHSD17B10BCHEPPARGPPARA
SCHEMBL451613 0.91 HTT (0.49) BCHE
SCHEMBL452122 0.91 TSHR (0.50) TSHRHSD17B10BCHEPPARGPPARA
SCHEMBL447970 0.90 BCHE (0.52) TSHRHSD17B10BCHE
SCHEMBL447899 0.88 BCHE (0.46) TSHRHSD17B10BCHEPPARGPPARA
SCHEMBL451365 0.88 HTT (0.46) BCHEPPARGPPARAACHE
SCHEMBL452358 0.86 TDP1 (0.49) TSHRBCHE
SCHEMBL451372 0.86 HTT (0.50) BCHE
SCHEMBL448483 0.86 LTA4H (0.53) BCHEPPARGPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1961303-B1 MICROENCAPSULATED PESTICIDE SUMITOMO CHEMICAL CO (JP) 2014-10-01 EP claimed
US-8653305-B2 Compound having S1P receptor binding potency and use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2014-02-18 US claimed
US-20090142406-A1 Microencapsulated Pesticide SUMITOMO CHEMICSL COMAPNY, LIMITED 2009-06-04 US claimed
EP-1961303-A1 MICROENCAPSULATED PESTICIDE Sumitomo Chemical Company, Limited (JP) 2008-08-27 EP claimed
CN-117024917-A Composite, molded article, and cured product 株式会社力森诺科 2023-11-10 CN disclosed
CN-113906091-B Composite, molded article, and cured product 株式会社力森诺科 2023-09-19 CN disclosed
CN-113906091-A Composite, molded article, and cured article 昭和电工材料株式会社 2022-01-07 CN disclosed
US-10350569-B2 Method for producing microcapsule SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2019-07-16 US disclosed
EP-2434876-B1 METHOD FOR PRODUCING MICROCAPSULES SUMITOMO CHEMICAL CO (JP) 2017-08-16 EP disclosed
US-9060510-B2 Microencapsulated pesticide SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-06-23 US disclosed
EP-1961303-B1 MICROENCAPSULATED PESTICIDE SUMITOMO CHEMICAL CO (JP) 2014-10-01 EP disclosed
US-8653305-B2 Compound having S1P receptor binding potency and use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2014-02-18 US disclosed
US-20120065070-A1 METHOD FOR PRODUCING MICROCAPSULE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-03-15 US disclosed
US-20120064060-A1 COMPOUND HAVING S1P RECEPTOR BINDING POTENCY AND USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2012-03-15 US disclosed
US-8039674-B2 Amino-substituted cyclic compound for EDG-1(endothelial differentiation gene) and/or EDG-6-mediated diseases; transplant rejection, autoimmune diseases, allergies, asthma, multiple organ failure, ischemia, reperfusion injury, lung or liver fibrosis; antitumor agents ONO PHARMACEUTICAL CO., LTD. (JP) 2011-10-18 US disclosed
WO-2010137743-A1 METHOD FOR PRODUCING MICROCAPSULE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-12-02 WO disclosed
US-20090142406-A1 Microencapsulated Pesticide SUMITOMO CHEMICSL COMAPNY, LIMITED 2009-06-04 US disclosed
US-20080207584-A1 Compound Having S1P Receptor Binding Potency and Use Thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2008-08-28 US disclosed
EP-1961303-A1 MICROENCAPSULATED PESTICIDE Sumitomo Chemical Company, Limited (JP) 2008-08-27 EP disclosed
EP-1760071-A1 COMPOUND HAVING S1P RECEPTOR BINDING POTENCY AND USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2007-03-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120064060-A1 COMPOUND HAVING S1P RECEPTOR BINDING POTENCY AND USE THEREOF S1PR1, S1PR3, EDNRA TSHR 743/4885HSD17B10 3356/4885BCHE 3683/4885
US-20120065070-A1 METHOD FOR PRODUCING MICROCAPSULE MCCC2, ACAT2, SRM TSHR 2415/4885HSD17B10 879/4885BCHE 670/4885
US-20080207584-A1 Compound Having S1P Receptor Binding Potency and Use Thereof S1PR1, EDNRA, S1PR3 TSHR 690/4885HSD17B10 3331/4885BCHE 3570/4885
US-10350569-B2 Method for producing microcapsule MCCC2, ACAT2, SRM TSHR 2415/4885HSD17B10 879/4885BCHE 670/4885
US-20090142406-A1 Microencapsulated Pesticide CHRM2, CHRM1, CHRM5 TSHR 1024/4885HSD17B10 286/4885BCHE 73/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.